December 2025

A Big Ten Cancer Research Consortium clinical trial, BTCRC-BRE15-024, titled “A phase I/II, single arm, nonrandomized study of ribociclib, a CDK 4/6 inhibitor, in combination with bicalutamide, an androgen receptor inhibitor, in advanced AR-positive triple-negative breast cancer,” (SABCS Poster # PS5-02-26) will be presented by Julia Knight-Shefner, MD, of the University of Wisconsin Carbone Cancer Center, as a poster at the 2025 San Antonio Breast Cancer Symposium. Read More

Nov. 19, 2025

The Big Ten Cancer Research Consortium is pleased to announce William P. Harris, MD, as a new member of the Big Ten CRC Steering Committee. Dr. Harris is a board-certified medical oncologist at Fred Hutchinson Cancer Center and UW Medical Center and serves as an associate professor in the Division of Hematology and Oncology at the University of Washington. Read More

Dec 2, 2025

A Big Ten CRC clinical trial, BTCRC-LUN18-363, titled, “Chemo-immunotherapy followed by durvalumab and ceralasertib in treatment naïve patients with extensive-stage small cell lung cancer,” led by Muhammad Furqan, MD, formerly of the University of Iowa, was featured as a proffered paper presentation at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin.  Read More

Nov. 12, 2025

The Big Ten Cancer Research Consortium is pleased to announce Gustavo Girotto, MD, as a new member of the Big Ten CRC Steering Committee. Dr. Girotto is a Clinical Professor of Internal Medicine in Hematology, Oncology, and Blood and Marrow Transplantation at the University of Iowa Holden Comprehensive Cancer Center. Read More

October 24, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights examples of discovery and impact from our member institutions. This issue covers a broad range of efforts to advance cancer research and care, from pioneering clinical trials and artificial intelligence diagnostics to novel immunotherapies, personalized treatments, and community-focused initiatives across Big Ten CRC member institutions. Read More

Oct. 7, 2025

At the 2025 Big Ten Cancer Research Consortium Summit on September 12, investigators from member institutions shared updates on several Big Ten CRC studies. These presentations underscored the collaborative, investigator-initiated work that drives the Big Ten CRC’s mission.

Nelson Yee, MD, PhD, of Penn State University.

Read More

From left: Kyle Nolla, PhD; Tom Jensen, Trustee of the Verna Mae Jessen Trust; and Roberto Benzo, PhD, at the 2025 Big Ten Cancer Research Consortium Summit.

Oct. 26, 2025

At the 2025 Big Ten Cancer Research Consortium Summit, investigators presented updates on two innovative research projects supported by the Kenneth and Verna Mae Jessen Award through the Big Ten CRC Foundation. Read More

Sept. 12, 2025:

The Big Ten Cancer Research Consortium congratulates Greg Durm, MD, on receiving the 2025 Pat Loehrer Award for Exemplary Collaboration in Cancer Research.

Read More

Sept. 12, 2025:

The Big Ten Cancer Research Consortium honored Howard Bailey, MD, with the 2025 Distinguished Leadership Award today during its annual Summit at Big Ten Conference Headquarters in Rosemont, Ill.

Read More

Sept. 3, 2025

The Big Ten Cancer Research Consortium and the University of Wisconsin–Madison are pleased to announce the 2025 Global Oncology Symposium on December 10, 2025. This annual event brings together clinicians, researchers, advocates, and thought leaders from around the world to advance the conversation on global cancer research and care. Read More